Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner

Institutional Investor · CIK 0002081668

ROYALTY PHARMA SUB-MANAGER, LLC

Portfolio data for the last 6 months — sourced from SEC 13F filings

Stocks Held

6

Total Value

$739.16M

Total Shares

33.98M

Latest Filing

Aug 21, 2026

CIK

0002081668

Current Holdings

Company↕Sector↕IndustryPeriod↕Filed↓Shares↕Value ($)↕Ownership↕TypeP/C/SSEC Filing
HealthcareBiotechnology2026-06-302026-08-14980,392$83.52M0.7879%SH—View
HealthcareBiotechnology2026-03-312026-08-21980,392$64.62M0.7879%SH—View
HealthcareBiotechnology2025-12-312026-08-21980,392$62.29M0.7879%SH—View
HealthcareBiotechnology2026-06-302026-08-142,388,150$60.61M3.6347%SH—View
HealthcareBiotechnology2026-06-302026-08-212,388,150$60.61M3.7827%SH—View
HealthcareBiotechnology2026-06-302026-08-142,455,357$54.09M1.8951%SH—View
HealthcareBiotechnology2026-03-312026-08-212,388,150$46.69M3.7827%SH—View
HealthcareBiotechnology2026-03-312026-05-142,388,150$46.69M3.6347%SH—View
HealthcareBiotechnology2025-12-312026-04-011,263,150$45.86M1.9225%SH—View
HealthcareBiotechnology2025-12-312026-08-211,263,150$45.86M2.0008%SH—View
HealthcareBiotechnology2026-06-302026-08-142,936,507$43.70M1.9504%SH—View
HealthcareBiotechnology2026-03-312026-08-213,846,154$36.62M1.5133%SH—View
HealthcareBiotechnology2025-12-312026-08-212,936,507$33.15M1.9504%SH—View
HealthcareBiotechnology2025-12-312026-08-213,846,154$30.00M1.5133%SH—View
HealthcareBiotechnology2026-03-312026-08-212,936,507$24.84M1.9504%SH—View
Showing 1 to 15 of 15 results
1